These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

365 related items for PubMed ID: 10341274

  • 1. Benefit of abciximab in patients with refractory unstable angina in relation to serum troponin T levels. c7E3 Fab Antiplatelet Therapy in Unstable Refractory Angina (CAPTURE) Study Investigators.
    Hamm CW, Heeschen C, Goldmann B, Vahanian A, Adgey J, Miguel CM, Rutsch W, Berger J, Kootstra J, Simoons ML.
    N Engl J Med; 1999 May 27; 340(21):1623-9. PubMed ID: 10341274
    [Abstract] [Full Text] [Related]

  • 2. Soluble CD40 ligand in acute coronary syndromes.
    Heeschen C, Dimmeler S, Hamm CW, van den Brand MJ, Boersma E, Zeiher AM, Simoons ML, CAPTURE Study Investigators.
    N Engl J Med; 2003 Mar 20; 348(12):1104-11. PubMed ID: 12646667
    [Abstract] [Full Text] [Related]

  • 3. Elevated troponin T and C-reactive protein predict impaired outcome for 4 years in patients with refractory unstable angina, and troponin T predicts benefit of treatment with abciximab in combination with PTCA.
    Lenderink T, Boersma E, Heeschen C, Vahanian A, de Boer MJ, Umans V, van den Brand MJ, Hamm CW, Simoons ML, CAPTURE Investigators.
    Eur Heart J; 2003 Jan 20; 24(1):77-85. PubMed ID: 12559939
    [Abstract] [Full Text] [Related]

  • 4. Predictive value of C-reactive protein and troponin T in patients with unstable angina: a comparative analysis. CAPTURE Investigators. Chimeric c7E3 AntiPlatelet Therapy in Unstable angina REfractory to standard treatment trial.
    Heeschen C, Hamm CW, Bruemmer J, Simoons ML.
    J Am Coll Cardiol; 2000 May 20; 35(6):1535-42. PubMed ID: 10807457
    [Abstract] [Full Text] [Related]

  • 5. Complementary clinical benefits of coronary-artery stenting and blockade of platelet glycoprotein IIb/IIIa receptors. Evaluation of Platelet IIb/IIIa Inhibition in Stenting Investigators.
    Lincoff AM, Califf RM, Moliterno DJ, Ellis SG, Ducas J, Kramer JH, Kleiman NS, Cohen EA, Booth JE, Sapp SK, Cabot CF, Topol EJ.
    N Engl J Med; 1999 Jul 29; 341(5):319-27. PubMed ID: 10423466
    [Abstract] [Full Text] [Related]

  • 6. Evidence for prevention of death and myocardial infarction with platelet membrane glycoprotein IIb/IIIa receptor blockade by abciximab (c7E3 Fab) among patients with unstable angina undergoing percutaneous coronary revascularization. EPIC Investigators. Evaluation of 7E3 in Preventing Ischemic Complications.
    Lincoff AM, Califf RM, Anderson KM, Weisman HF, Aguirre FV, Kleiman NS, Harrington RA, Topol EJ.
    J Am Coll Cardiol; 1997 Jul 29; 30(1):149-56. PubMed ID: 9207636
    [Abstract] [Full Text] [Related]

  • 7. Early and late clinical outcome following coronary angioplasty performed with platelet glycoprotein IIb/IIIa receptor inhibition: the EPIC Trial results.
    Popma JJ, Satler LF.
    J Invasive Cardiol; 1994 Jul 29; 6 Suppl A():19A-28A; discussion 45A-50A. PubMed ID: 10155090
    [Abstract] [Full Text] [Related]

  • 8. Troponin T levels in patients with acute coronary syndromes, with or without renal dysfunction.
    Aviles RJ, Askari AT, Lindahl B, Wallentin L, Jia G, Ohman EM, Mahaffey KW, Newby LK, Califf RM, Simoons ML, Topol EJ, Berger P, Lauer MS.
    N Engl J Med; 2002 Jun 27; 346(26):2047-52. PubMed ID: 12087140
    [Abstract] [Full Text] [Related]

  • 9. Angiographic findings in patients with refractory unstable angina according to troponin T status.
    Heeschen C, van Den Brand MJ, Hamm CW, Simoons ML.
    Circulation; 1999 Oct 05; 100(14):1509-14. PubMed ID: 10510053
    [Abstract] [Full Text] [Related]

  • 10. Randomized trial of a GPIIb/IIIa platelet receptor blocker in refractory unstable angina. European Cooperative Study Group.
    Simoons ML, de Boer MJ, van den Brand MJ, van Miltenburg AJ, Hoorntje JC, Heyndrickx GR, van der Wieken LR, de Bono D, Rutsch W, Schaible TF.
    Circulation; 1994 Feb 05; 89(2):596-603. PubMed ID: 7508826
    [Abstract] [Full Text] [Related]

  • 11. Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with the glycoprotein IIb/IIIa inhibitor tirofiban.
    Cannon CP, Weintraub WS, Demopoulos LA, Vicari R, Frey MJ, Lakkis N, Neumann FJ, Robertson DH, DeLucca PT, DiBattiste PM, Gibson CM, Braunwald E, TACTICS (Treat Angina with Aggrastat and Determine Cost of Therapy with an Invasive or Conservative Strategy)--Thrombolysis in Myocardial Infarction 18 Investigators.
    N Engl J Med; 2001 Jun 21; 344(25):1879-87. PubMed ID: 11419424
    [Abstract] [Full Text] [Related]

  • 12. Comparison of two platelet glycoprotein IIb/IIIa inhibitors, tirofiban and abciximab, for the prevention of ischemic events with percutaneous coronary revascularization.
    Topol EJ, Moliterno DJ, Herrmann HC, Powers ER, Grines CL, Cohen DJ, Cohen EA, Bertrand M, Neumann FJ, Stone GW, DiBattiste PM, Demopoulos L, TARGET Investigators. Do Tirofiban and ReoPro Give Similar Efficacy Trial.
    N Engl J Med; 2001 Jun 21; 344(25):1888-94. PubMed ID: 11419425
    [Abstract] [Full Text] [Related]

  • 13. Randomised placebo-controlled trial of abciximab before and during coronary intervention in refractory unstable angina: the CAPTURE Study.
    Lancet; 1997 May 17; 349(9063):1429-35. PubMed ID: 9164316
    [Abstract] [Full Text] [Related]

  • 14. Safety and efficacy of the platelet glycoprotein IIb/IIIa inhibitor abciximab in Chinese patients undergoing high-risk angioplasty.
    Chen YH, Chen JW, Wu TC, Ding PY, Wang SP, Chang MS.
    Zhonghua Yi Xue Za Zhi (Taipei); 2000 Jan 17; 63(1):8-15. PubMed ID: 10645045
    [Abstract] [Full Text] [Related]

  • 15. A clinical trial of abciximab in elective percutaneous coronary intervention after pretreatment with clopidogrel.
    Kastrati A, Mehilli J, Schühlen H, Dirschinger J, Dotzer F, ten Berg JM, Neumann FJ, Bollwein H, Volmer C, Gawaz M, Berger PB, Schömig A, Intracoronary Stenting and Antithrombotic Regimen-Rapid Early Action for Coronary Treatment Study Investigators.
    N Engl J Med; 2004 Jan 15; 350(3):232-8. PubMed ID: 14724302
    [Abstract] [Full Text] [Related]

  • 16. The prognostic value of serum troponin T in unstable angina.
    Hamm CW, Ravkilde J, Gerhardt W, Jørgensen P, Peheim E, Ljungdahl L, Goldmann B, Katus HA.
    N Engl J Med; 1992 Jul 16; 327(3):146-50. PubMed ID: 1290492
    [Abstract] [Full Text] [Related]

  • 17. Abciximab in patients with acute coronary syndromes undergoing percutaneous coronary intervention after clopidogrel pretreatment: the ISAR-REACT 2 randomized trial.
    Kastrati A, Mehilli J, Neumann FJ, Dotzer F, ten Berg J, Bollwein H, Graf I, Ibrahim M, Pache J, Seyfarth M, Schühlen H, Dirschinger J, Berger PB, Schömig A, Intracoronary Stenting and Antithrombotic: Regimen Rapid Early Action for Coronary Treatment 2 (ISAR-REACT 2) Trial Investigators.
    JAMA; 2006 Apr 05; 295(13):1531-8. PubMed ID: 16533938
    [Abstract] [Full Text] [Related]

  • 18. Elevated placental growth factor levels are associated with adverse outcomes at four-year follow-up in patients with acute coronary syndromes.
    Lenderink T, Heeschen C, Fichtlscherer S, Dimmeler S, Hamm CW, Zeiher AM, Simoons ML, Boersma E, CAPTURE Investigators.
    J Am Coll Cardiol; 2006 Jan 17; 47(2):307-11. PubMed ID: 16412852
    [Abstract] [Full Text] [Related]

  • 19. Assessment of coronary angiograms prior to and after treatment with abciximab, and the outcome of angioplasty in refractory unstable angina patients. Angiographic results from the CAPTURE trial.
    van den Brand M, Laarman GJ, Steg PG, De Scheerder I, Heyndrickx G, Beatt K, Kootstra J, Simoons ML.
    Eur Heart J; 1999 Nov 17; 20(21):1572-8. PubMed ID: 10529325
    [Abstract] [Full Text] [Related]

  • 20. [Stratification of cardiac risk in unstable angina: value of troponin measurements].
    Chérif A, Messaoudi H, Mourali S, Ezzar T, Boussaada R, Mechmèche R.
    Tunis Med; 2002 Oct 17; 80(10):581-3. PubMed ID: 12632750
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.